MedTrace Logo

Evaluation Study of SPOTme® Skin Cancer Screenings

NCT03564769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 431

Last updated 2019-08-13

No results posted yet for this study

Summary

This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Conditions

Interventions

BEHAVIORAL

Intervention Arm

Individuals randomized to the intervention group will receive skin cancer screening educational materials.

OTHER

AAD SPOTmeⓇ skin cancer screening

All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.

Sponsors & Collaborators

  • American Academy of Dermatology (AAD)

    collaborator UNKNOWN

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Alan Geller, MPH, RN · Harvard TH Chan School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-10-01
Completion
2019-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564769 on ClinicalTrials.gov